The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Mutant GNAS drives pancreatic tumourigenesis by inducing PKA-mediated SIK suppression and reprogramming lipid metabolism
Open accessAbstract
G protein α s (GNAS) mediates receptor-stimulated cAMP signalling, which integrates diverse environmental cues with intracellular responses. GNAS is mutationally activated in multiple tumour types, although its oncogenic mechanisms remain elusive. We explored this question in pancreatic tumourigenesis where concurrent GNAS and KRAS mutations characterize pancreatic ductal adenocarcinomas (PDAs) arising from intraductal papillary mucinous neoplasms (IPMNs). By developing genetically engineered mouse models, we show that Gnas R201C cooperates with Kras G12D to promote initiation of IPMN, which progress to invasive PDA following Tp53 loss. Mutant Gnas remains critical for tumour maintenance in vivo. This is driven by protein-kinase-A-mediated suppression of salt-inducible kinases (Sik1-3), associated with induction of lipid remodelling and fatty acid oxidation. Comparison of Kras-mutant pancreatic cancer cells with and without Gnas mutations reveals striking differences in the functions of this network. Thus, we uncover Gnas-driven oncogenic mechanisms, identify Siks as potent tumour suppressors, and demonstrate unanticipated metabolic heterogeneity among Kras-mutant pancreatic neoplasms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“More recent IPMN models have been generated that genocopy recurrent driver alterations observed in cognate human lesions (i.e. Kras, Gnas, Rnf43) (Fig 1)34–36, and these models demonstrate the comparable stepwise progression observed in patient derived IPMNs.”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [35]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Improved vectors and genome-wide libraries for CRISPR screening
Sanjana, N. E., Shalem, O., & Zhang, F. (2014) · Nature Methods · doi:10.1038/nmeth.3047 · Cited by 5,239
Genomic analyses identify molecular subtypes of pancreatic cancer
Bailey, P., Chang, D. K., Nones, K., Johns, A. L., Patch, A.-M., Gingras, M.-C., Miller, D. K., Christ, A. N., Bruxner, T. J. C., Quinn, M. C., et al. (2016) · Nature · doi:10.1038/nature16965 · Cited by 3,621
Zehir, A., Benayed, R., Shah, R. H., Syed, A., Middha, S., Kim, H. R., Srinivasan, P., Gao, J., Chakravarty, D., Devlin, S. M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4333 · Cited by 3,380
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941
Trends in GPCR drug discovery: new agents, targets and indications
Hauser, A. S., Attwood, M. M., Rask‐Andersen, M., Schiöth, H. B., & Gloriam, D. E. I. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.178 · Cited by 2,714
Cellular Fatty Acid Metabolism and Cancer
Currie, E., Schulze, A., Zechner, R., Walther, T. C., & Farese, R. V. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.05.017 · Cited by 2,123
Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism
Ying, H., Kimmelman, A. C., Lyssiotis, C. A., Hua, S., Chu, G. C., Fletcher-Sananikone, E., Locasale, J. W., Son, J., Zhang, H., Coloff, J. L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.058 · Cited by 2,043
Integrated genomic characterization of pancreatic ductal adenocarcinoma
Raphael, B. J., Hruban, R. H., Aguirre, A. J., Moffitt, R. A., Yeh, J. J., Stewart, C., Robertson, A. G., Cherniack, A. D., Gupta, M., Getz, G., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.07.007 · Cited by 2,019
Self-citationThe LKB1-AMPK pathway: metabolism and growth control in tumour suppression
Shackelford, D. B., & Shaw, R. J. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2676 · Cited by 1,943
Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling
Yu, F.-X., Zhao, B., Panupinthu, N., Jewell, J. L., Lian, I., Wang, L. H., Zhao, J., Yuan, H., Tumaneng, K., Li, H., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.037 · Cited by 1,628
Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function
Viale, A., Pettazzoni, P., Lyssiotis, C. A., Ying, H., Sánchez, N., Marchesini, M., Carugo, A., Green, T., Seth, S., Giuliani, V., et al. (2014) · Nature · doi:10.1038/nature13611 · Cited by 1,259
FAT SIGNALS - Lipases and Lipolysis in Lipid Metabolism and Signaling
Zechner, R., Zimmermann, R., Eichmann, T. O., Kohlwein, S. D., Haemmerle, G., Lass, A., & Madeo, F. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.12.018 · Cited by 1,169
Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets
Witkiewicz, A. K., McMillan, E. A., Balaji, U., Baek, G., Lin, W.-C., Mansour, J., Mollaee, M., Wagner, K.-U., Koduru, P., Yopp, A., et al. (2015) · Nature Communications · doi:10.1038/ncomms7744 · Cited by 1,115
CREB and the CRTC co-activators: sensors for hormonal and metabolic signals
Altarejos, J. Y., & Montminy, M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3072 · Cited by 1,061
Aguirre, A. J., Bardeesy, N., Sinha, M., Lopez, L., Tuveson, D. A., Horner, J., Redston, M. S., & DePinho, R. A. (2003) · Genes & Development · doi:10.1101/gad.1158703 · Cited by 1,033
Self-citationThe role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors
Kawaguchi, Y., Cooper, B., Gannon, M., Ray, M., MacDonald, R. J., & Wright, C. V. E. (2002) · Nature Genetics · doi:10.1038/ng959 · Cited by 1,007
Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis
Nomura, D. K., Long, J. Z., Niessen, S., Hoover, H. S., Ng, S.-W., & Cravatt, B. F. (2010) · Cell · doi:10.1016/j.cell.2009.11.027 · Cited by 1,002
Self-citationInhibition of the EGF-Activated MAP Kinase Signaling Pathway by Adenosine 3′,5′-Monophosphate
Wu, J., Dent, P., Jelı́nek, T., Wolfman, A., Weber, M. J., & Sturgill, T. W. (1993) · Science · doi:10.1126/science.7694366 · Cited by 919
Prostaglandin E 2 Promotes Colon Cancer Cell Growth Through a G s -Axin-ß-Catenin Signaling Axis
Castellone, M. D., Teramoto, H., Williams, B. O., Druey, K. M., & Gutkind, J. S. (2005) · Science · doi:10.1126/science.1116221 · Cited by 893
Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Development
Wu, J., Matthaei, H., Maitra, A., Molin, M. D., Wood, L., Eshleman, J., Goggins, M., Canto, M., Schulick, R., Edil, B., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002543 · Cited by 786
Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice
Collins, M. A., Bednar, F., Zhang, Y., Brisset, J.-C., Galbán, S., Galbán, C. J., Rakshit, S., Flannagan, K. S., Adsay, N. V., & Pasca di Magliano, M. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59227 · Cited by 770
Peroxisomes: A Nexus for Lipid Metabolism and Cellular Signaling
Lodhi, I. J., & Semenkovich, C. F. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.01.002 · Cited by 605
The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer
O’Hayre, M., Vázquez‐Prado, J., Kufareva, I., Stawiski, E. W., Handel, T. M., Seshagiri, S., & Gutkind, J. S. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3521 · Cited by 559
The Cyclic AMP PathwayPreprint
Sassone‐Corsi, P. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a011148 · Cited by 555
Metabolic Signatures Uncover Distinct Targets in Molecular Subsets of Diffuse Large B Cell Lymphoma
Caro, P., Kishan, A. U., Norberg, E., Stanley, I. A., Chapuy, B., Ficarro, S. B., Polak, K. Z., Tondera, D., Gounarides, J., Yin, H. X., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.08.014 · Cited by 537
Probing tumor phenotypes using stable and regulated synthetic microRNA precursors
Dickins, R. A., Hemann, M. T., Zilfou, J. T., Simpson, D. R., Ibarra, I., Hannon, G. J., & Lowe, S. W. (2005) · Nature Genetics · doi:10.1038/ng1651 · Cited by 522
Detection of a Recurrent DNAJB1-PRKACA Chimeric Transcript in Fibrolamellar Hepatocellular Carcinoma
Honeyman, J. N., Simon, E. P., Robine, N., Chiaroni-Clarke, R. C., Darcy, D. G., Lim, I. I. P., Gleason, C. E., Murphy, J. M., Rosenberg, B. R., Teegan, L., et al. (2014) · Science · doi:10.1126/science.1249484 · Cited by 491
Beard, C., Hochedlinger, K., Plath, K., Wutz, A., & Jaenisch, R. (2006) · genesis · doi:10.1002/gene.20180 · Cited by 482
Mammary adipocytes stimulate breast cancer invasion through metabolic remodeling of tumor cells
Wang, Y. Y., Attané, C., Milhas, D., Dirat, B., Dauvillier, S., Guérard, A., Gilhodes, J., Lazar, I., Alet, N., Laurent, V., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.87489 · Cited by 458
Amato, E., Molin, M. D., Mafficini, A., Yu, J. Q., Malleo, G., Rusev, B. C., Fassan, M., Antonello, D., Sadakari, Y., Castelli, P., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4344 · Cited by 350
Gerhart‐Hines, Z., Dominy, J. E., Blättler, S. M., Jedrychowski, M. P., Banks, A. S., Lim, J.-H., Chim, H., Gygi, S. P., & Puigserver, P. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.12.005 · Cited by 336
Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability
Pattabiraman, D. R., Bierie, B., Kober, K. I., Thiru, P., Krall, J. A., Zill, C., Reinhardt, F., Tam, W. L., & Weinberg, R. A. (2016) · Science · doi:10.1126/science.aad3680 · Cited by 332
The metabolic fate of acetate in cancer
Schug, Z. T., Vande Voorde, J., & Gottlieb, E. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.87 · Cited by 331
Bricambert, J., Miranda, J., Benhamed, F., Girard, J. R., Postic, C., & Dentin, R. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41624 · Cited by 318
Padanad, M. S., Konstantinidou, G., Venkateswaran, N., Melegari, M., Rindhe, S., Mitsche, M. A., Yang, C., Batten, K. G., Huffman, K. E., Liu, J., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.07.009 · Cited by 312
Mino-Kenudson, M. A., Castillo, C. F.-D., Baba, Y., Valsangkar, N. P., Liss, A. S., Hsu, M., Correa‐Gallego, C., Ingkakul, T., Johnston, R. P., Turner, B. G., et al. (2011) · Gut · doi:10.1136/gut.2010.232272 · Cited by 292
Self-citationClark, K., MacKenzie, K. F., Petkevicius, K., Kristariyanto, Y. A., Zhang, J., Choi, H. G., Peggie, M. W., Plater, L., Pedrioli, P. G. A., McIver, E., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1215450109 · Cited by 260
A Hormone-Dependent Module Regulating Energy Balance
Wang, B., Moya, N., Niessen, S., Hoover, H. S., Mihaylova, M. M., Shaw, R. J., Yates, J. R., Fischer, W. H., Thomas, J. B., & Montminy, M. (2011) · Cell · doi:10.1016/j.cell.2011.04.013 · Cited by 242
Benjamin, D. I., Cozzo, A. J., Ji, X., Roberts, L. S., Louie, S. M., Mulvihill, M. M., Luo, K., & Nomura, D. K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310894110 · Cited by 237
Self-citationPancreatic Cystic Neoplasms: Management and Unanswered Questions
Farrell, J. J., & Castillo, C. F. F.-D. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.01.073 · Cited by 223
Self-citationLim, J.-H., Gerhart-Hines, Z., Dominy, J. E., Lee, Y., Kim, S., Tabata, M., Xiang, Y. K., & Puigserver, P. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.415729 · Cited by 212
von Figura, G., Fukuda, A., Roy, N., Liku, M. E., Morris IV, J. P., Kim, G. E., Russ, H. A., Firpo, M. A., Mulvihill, S. J., Dawson, D. W., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb2916 · Cited by 190
The LKB1-salt-inducible kinase pathway functions as a key gluconeogenic suppressor in the liver
Patel, K., Foretz, M., Marion, A., Campbell, D. G., Gourlay, R., Boudaba, N., Tournier, E., Titchenell, P. M., Peggie, M. W., Deák, M., et al. (2014) · Nature Communications · doi:10.1038/ncomms5535 · Cited by 171
Self-citationMiranda, F., Mannion, D., Liu, S., Zheng, Y., Mangala, L. S., Redondo, C., Herrero‐González, S., Xu, R., Taylor, C., Fotso, D. C., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.06.020 · Cited by 167
SIK1 Couples LKB1 to p53-Dependent Anoikis and Suppresses Metastasis
Cheng, H.-L. M., Liu, P., Wang, Z. C., Zou, L., Santiago, S., Garbitt, V. M., Gjoerup, O. V., Iglehart, J. D., Miron, A., Richardson, A. L., et al. (2009) · Science Signaling · doi:10.1126/scisignal.2000369 · Cited by 162
Glycerolipid/free fatty acid cycle and islet β-cell function in health, obesity and diabetes
Prentki, M., & Madiraju, S. R. M. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.11.004 · Cited by 160
Measurement of Fatty Acid Oxidation Rates in Animal Tissues and Cell Lines
Huynh, F. K., Green, M. F., Koves, T. R., & Hirschey, M. D. (2014) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-416618-9.00020-0 · Cited by 154
Louie, S. M., Roberts, L. S., Mulvihill, M. M., Luo, K., & Nomura, D. K. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.07.008 · Cited by 154
Self-citationLapek, J. D., Greninger, P., Morris, R. T., Amzallag, A., Pruteanu-Malinici, I., Benes, C. H., & Haas, W. (2017) · Nature Biotechnology · doi:10.1038/nbt.3955 · Cited by 152
Self-citationGSTP1 Is a Driver of Triple-Negative Breast Cancer Cell Metabolism and Pathogenicity
Louie, S. M., Grossman, E. A., Crawford, L. A., Ding, L., Camarda, R., Huffman, T. R., Miyamoto, D. K., Goga, A., Weerapana, E., & Nomura, D. K. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2016.03.017 · Cited by 149
Self-citationIglesias‐Bartolomé, R., Torres, D., Marone, R., Feng, X., Martı́n, D., Simaan, M., Chen, M., Weinstein, L. S., Taylor, S. S., Molinolo, A., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3164 · Cited by 147
Integrated phenotypic and activity-based profiling links Ces3 to obesity and diabetes
Domínguez, E., Galmozzi, A., Chang, J. W., Hsu, K., Pawlak, J., Li, W., Godio, C., Thomas, J. R., Partida, D., Niessen, S., et al. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1429 · Cited by 137
Self-citationPKA inhibits WNT signalling in adrenal cortex zonation and prevents malignant tumour development
Drelon, C., Berthon, A., Sahut-Barnola, I., Mathieu, M., Dumontet, T., Rodriguez, S., Batisse-Lignier, M., Tabbal, H., Tauveron, I., Lefrançois-Martinez, A.-M., et al. (2016) · Nature Communications · doi:10.1038/ncomms12751 · Cited by 128
Patra, K. C., Bardeesy, N. M., & Mizukami, Y. (2017) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2017.3 · Cited by 127
Self-citationThe G protein α subunit Gαs is a tumor suppressor in Sonic hedgehog−driven medulloblastoma
He, X., Zhang, L., Chen, Y., Remke, M., Shih, D. J. H., Lu, F., Wang, H., Deng, Y., Yu, Y., Xia, Y., et al. (2014) · Nature Medicine · doi:10.1038/nm.3666 · Cited by 125
Xing, F., Luan, Y., Cai, J., Wu, S., Mai, J., Gu, J., Zhang, H., Li, K., Lin, Y., Xiao, X., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.037 · Cited by 120
Salt-inducible kinases regulate growth through the Hippo signalling pathway in Drosophila
Wehr, M. C., Holder, M. V., Gailite, I., Saunders, R. E., Maile, T. M., Ciirdaeva, E., Instrell, R., Jiang, M., Howell, M. T., Rossner, M. J., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2658 · Cited by 109
Hepatobiliary and Pancreatic Neoplasms in Patients With McCune-Albright Syndrome
Gaujoux, S., Salenave, S., Ronot, M., Rangheard, A. ‐., Cros, J. F., Belghiti, J., Sauvanet, A., Ruszniewski, P. B., & Chanson, P. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1823 · Cited by 92
Protein kinase A and its role in human neoplasia: the Carney complex paradigm.
Bossis, I., Voutetakis, A., Bei, T. A., Sandrini, F., Griffin, K., & Stratakis, C. A. (2004) · Endocrine Related Cancer · doi:10.1677/erc.0.0110265 · Cited by 91
Isolation, culture and genetic manipulation of mouse pancreatic ductal cells
Reichert, M., Takano, S., Heeg, S., Bakir, B. S., Botta, G., & Rustgi, A. (2013) · Nature Protocols · doi:10.1038/nprot.2013.079 · Cited by 89
A genetic and molecular update on adrenocortical causes of Cushing syndrome
Lodish, M. B., & Stratakis, C. A. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.24 · Cited by 88
SIK2 Is Critical in the Regulation of Lipid Homeostasis and Adipogenesis In Vivo
Park, J., Yoon, Y.-S., Han, H.-S., Kim, Y., Ogawa, Y., Park, K., Lee, C., Kim, S., & Koo, S. (2014) · Diabetes · doi:10.2337/db13-1423 · Cited by 76
14‐3‐3 proteins mediate inhibitory effects of cAMP on salt‐inducible kinases ( SIK s)
Sonntag, T., Vaughan, J. M., & Montminy, M. (2017) · FEBS Journal · doi:10.1111/febs.14351 · Cited by 68
Taki, K., Ohmuraya, M., Tanji, E., Komatsu, H., Hashimoto, D., Semba, K., Araki, K., Kawaguchi, Y., Baba, H., & Furukawa, T. (2016) · Oncogene · doi:10.1038/onc.2015.294 · Cited by 64
Cholesterol-Independent SREBP-1 Maturation Is Linked to ARF1 Inactivation
Smulan, L. J., Ding, W., Freinkman, E., Gujja, S., Edwards, Y. J. K., & Walker, A. K. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.05.086 · Cited by 55
Gαs regulates the post-endocytic sorting of G protein-coupled receptors
Rosciglione, S., Thériault, C., Boily, M.-O., Paquette, M., & Lavoie, C. L. (2014) · Nature Communications · doi:10.1038/ncomms5556 · Cited by 50
Li, Y., Shrestha, Y. B., Chen, M., Chanturiya, T., Gavrilova, O., & Weinstein, L. S. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1517142113 · Cited by 35
Wilderman, A. S., Guo, Y., Divakaruni, A. S., Perkins, G. A., Zhang, L., Murphy, A. N., Taylor, S. S., & Insel, P. A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.658153 · Cited by 11
GNAS Mutations: Drivers or Co-Pilots? Yet, Promising Diagnostic Biomarkers
Innamorati, G., Valenti, M. T., Giacomello, L., Carbonare, L. D., & Bassi, C. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.05.005 · Cited by 9
Cited by
Sorted by citations
Pancreatic cancer: Advances and challenges
Halbrook, C. J., Lyssiotis, C. A., Pasca di Magliano, M., & Maitra, A. (2023) · Cell · doi:10.1016/j.cell.2023.02.014 · Cited by 1,321
Complex roles of cAMP–PKA–CREB signaling in cancer
Zhang, H., Kong, Q., Wang, J., Jiang, Y., & Hua, H. M. (2020) · Experimental Hematology and Oncology · doi:10.1186/s40164-020-00191-1 · Cited by 472
Tumor-induced neurogenesis and immune evasion as targets of innovative anti-cancer therapies
Cervantes‐Villagrana, R. D., Albores‐García, D., Cervantes-Villagrana, A. R., & García-Acevez, S. J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0205-z · Cited by 311
Metabolic reprogramming in cancer: Mechanisms and therapeutics
Nong, S., Han, X., Yu, X., Qian, Y., Wei, Y., Zhang, T., Tian, K., Shen, K., Yang, J., & Ma, X. (2023) · MedComm · doi:10.1002/mco2.218 · Cited by 313
Omori, Y., Ono, Y., Tanino, M. A., Karasaki, H., Yamaguchi, H., Furukawa, T., Enomoto, K., Ueda, J., Sumi, A., Katayama, J., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.10.029 · Cited by 189
Self-citation
Metadata
- Authors
- Patra, K. C., Kato, Y., Mizukami, Y., Widholz, S., Boukhali, M., Revenco, I., Grossman, E. A., Ji, F., Sadreyev, R. I., Liss, A. S., Screaton, R. A., Sakamoto, K., Ryan, D. P., Mino-Kenudson, M., Castillo, C. F.-D., Nomura, D. K., Haas, W., & Bardeesy, N.
- Affiliations
- Harvard University (US)
- Massachusetts General Hospital (US)
- Asahikawa Medical University (JP)
- University of California, Berkeley (US)
- University of Toronto (CA)
- University of Dundee (GB)
- Corresponding author
- Bardeesy, Nabeel
- ORCID
- Venue
- Nature Cell Biology
- Published
- 2018-06-25
- Volume
- 20
- Issue
- 7
- Pages
- 811-822
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- PMC
- PMC6044476
- OpenAlex
- W2809279418
- Cited by
- 192
- References
- 70
- Citations by year
- 2026: 10 · 2025: 35 · 2024: 31 · 2023: 29 · 2022: 21 · 2021: 28 · 2020: 14 · 2019: 19 · 2018: 5
- FWCI
- 6.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Japan Society for the Promotion of Science (17K09472)
- National Cancer Institute (P50CA127003, R01CA133557, P01CA117969)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK040561)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- GNAS, pancreatic ductal adenocarcinoma, intraductal papillary mucinous neoplasm, KRAS G12D, cAMP signaling, protein kinase A, salt-inducible kinases, lipid remodeling, fatty acid oxidation, cancer metabolism, p53 deficiency, tumour suppressor, oncogenic mechanisms
- MeSH terms
- Animals, Cell Transformation, Neoplastic, Chromogranins, Enzyme Repression, Fatty Acids, Female, Humans, Male, Mice, Inbred C57BL, Mice, Mutant Strains, Mice, Transgenic, Mutation, Oxidation-Reduction, Pancreatic Neoplasms, Phenotype, Genes, ras, Time Factors, Tumor Cells, Cultured, Signal Transduction, Gene Expression Regulation, Neoplastic, Tumor Suppressor Protein p53, Mice, Inbred NOD, Protein Serine-Threonine Kinases, Cyclic AMP-Dependent Protein Kinases, GTP-Binding Protein alpha Subunits, Gs, Genetic Predisposition to Disease, Carcinoma, Pancreatic Ductal, Cell Line, Tumor, Lipid Metabolism, Mice, 129 Strain, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
